Henry Ly Chan
Professor and Director
Medicine & Therapeutics
The Chinese University of Hong Kong
Hong Kong
Biography
Dr. Henry LY Chan is affiliated to Medicine & Therapeutics, CUHK . Dr. Henry LY Chan is currently providing services as Professor and Director. Dr. Henry LY Chan has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Henry LY Chan contributions have acclaimed recognition from honourable subject experts around the world. Dr. Henry LY Chan is actively associated with different societies and academies. Dr. Henry LY Chan academic career is decorated with several reputed awards and funding. Dr. Henry LY Chan research interests include Viral hepatitis, liver fibrosis, liver cancer, anti-viral therapy, fatty liver disease.
Research Interest
Specialist in Gastroenterology and Hepatology
Publications
-
JC Hsiang, GLH Wong, YK Tse, VWS Wong, TCF Yip, HLY Chan. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: a propensity-score landmark analysis. J Hepatol 2015;63:1190-7.
-
GLH Wong, YK Tse, VWS Wong, TY Fung, KK Choi, HLY Chan. Long-term safety of oral nucleos(t)ide analogues for patients with chronic hepatitis B – a cohort study of 53,500 subjects. Hepatology 2015;62:684-93.
-
R Zhu, MTS Mok, W Kang, SSK Lau, WK Yip, Y Chen, PBS Lai, VWS Wong, KF To, JJY Sung, ASL Cheng, HLY Chan. Truncated HBx-dependent silencing of growth arrest-specific 2 promotes hepatocarcinogenesis through inhibition of p53-mediated apoptosis. J Pathol 2015;237:38-49.
